The technology is intended to treat distal radius fractures. It has received approval from the U.S. Food and Drug Administration as well as received a CE Mark.
The credit facility is provided by Oxford Finance and Square 1 Bank.
Conventus is a medical device company focused on creating less invasive solutions to treat a broad range of challenging peri-articular fractures.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
